肾内科指南

订阅

MedSci主页 / 所有栏目 / 肾内科指南

中国高尿酸血症与相关疾病诊疗多学科专家共识（英文版）

2017-10-20 肾脏病相关专家小组（统称） Chin Med J (Engl). 2017 Oct 20;130(20):2473-2488.

高尿酸血症

我国高尿酸血症(hypemricemia，HUA)的患病率逐年增高，并呈年轻化趋势，已成为仅次于糖尿病的第二大代谢性疾病。血尿酸升高除可引起痛风之外，还与肾脏、内分泌代谢、心脑血管等系统疾病的发生和发展有关。既往部分学科已从本专业出发制定了相关临床指南或专家共识，各有侧重。本共识参照系统医学模式，邀请风湿免疫、肾脏、内分泌代谢、心血管、神经、泌尿和中医科等学科专家共同讨论、制定而成，是我国HUA相

中文标题：

中国高尿酸血症与相关疾病诊疗多学科专家共识（英文版）

英文标题：

Chinese Multidisciplinary Expert Consensus on the Diagnosis and Treatment of Hyperuricemia and Related Diseases

发布机构：

肾脏病相关专家小组（统称）

发布日期：

2017-10-20

简要介绍：

我国高尿酸血症(hypemricemia，HUA)的患病率逐年增高，并呈年轻化趋势，已成为仅次于糖尿病的第二大代谢性疾病。血尿酸升高除可引起痛风之外，还与肾脏、内分泌代谢、心脑血管等系统疾病的发生和发展有关。既往部分学科已从本专业出发制定了相关临床指南或专家共识，各有侧重。本共识参照系统医学模式，邀请风湿免疫、肾脏、内分泌代谢、心血管、神经、泌尿和中医科等学科专家共同讨论、制定而成，是我国HUA相关疾病的首个多学科专家共识，旨在推动多学科协作，指导和规范HUA相关疾病的临床实践。

 

拓展指南：与高尿酸血症相关指南：

相关资料下载：
[AttachmentFileName(sort=100, fileName=中国高尿酸血症与相关疾病诊疗多学科专家共识（英文版）)] GetToolGuiderByIdResponse(projectId=1, id=01f4f1c00151a207, title=中国高尿酸血症与相关疾病诊疗多学科专家共识（英文版）, enTitle=Chinese Multidisciplinary Expert Consensus on the Diagnosis and Treatment of Hyperuricemia and Related Diseases, guiderFrom=Chin Med J (Engl). 2017 Oct 20;130(20):2473-2488., authorId=null, author=, summary=我国高尿酸血症(hypemricemia，HUA)的患病率逐年增高，并呈年轻化趋势，已成为仅次于糖尿病的第二大代谢性疾病。血尿酸升高除可引起痛风之外，还与肾脏、内分泌代谢、心脑血管等系统疾病的发生和发展有关。既往部分学科已从本专业出发制定了相关临床指南或专家共识，各有侧重。本共识参照系统医学模式，邀请风湿免疫、肾脏、内分泌代谢、心血管、神经、泌尿和中医科等学科专家共同讨论、制定而成，是我国HUA相, cover=, journalId=null, articlesId=null, associationId=283, associationName=肾脏病相关专家小组（统称）, associationIntro=本制定者非特指某个专家小组。, copyright=0, guiderPublishedTime=Fri Oct 20 00:00:00 CST 2017, originalUrl=, linkOutUrl=, content=<P>我国高尿酸血症(hypemricemia，HUA)的患病率逐年增高，并呈年轻化趋势，已成为仅次于糖尿病的第二大代谢性疾病。血尿酸升高除可引起痛风之外，还与肾脏、内分泌代谢、心脑血管等系统疾病的发生和发展有关。既往部分学科已从本专业出发制定了相关临床指南或专家共识，各有侧重。本共识参照系统医学模式，邀请风湿免疫、肾脏、内分泌代谢、心血管、神经、泌尿和中医科等学科专家共同讨论、制定而成，是我国HUA相关疾病的首个多学科专家共识，旨在推动多学科协作，指导和规范HUA相关疾病的临床实践。 </P> <P> </P>拓展指南：<strong>与<font color=red>高尿酸血症</font>相关指南：</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=c90d11c001a89993" title="中国慢性肾脏病患者合并高尿酸血症诊治专家共识" target=_blank>中国慢性肾脏病患者合并高尿酸血症诊治专家共识</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=49edf1c001a831fd" title="中国高尿酸血症相关疾病诊疗多学科专家共识" target=_blank>中国高尿酸血症相关疾病诊疗多学科专家共识</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=e87e71c001a66100" title="中国肾脏疾病高尿酸血症诊治的实践指南（2017版）" target=_blank>中国肾脏疾病高尿酸血症诊治的实践指南（2017版）</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=a756b1c00119800b" title="高尿酸血症和痛风治疗的中国专家共识" target=_blank>高尿酸血症和痛风治疗的中国专家共识</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=896b71c0010296d7" title="2013高尿酸血症和痛风治疗中国专家共识-期刊版" target=_blank>2013高尿酸血症和痛风治疗中国专家共识-期刊版</a></li> 更多信息请点击：<a href="http://www.medsci.cn/guideline/list.do?q=%E9%AB%98%E5%B0%BF%E9%85%B8%E8%A1%80%E7%97%87" target=_blank>有关高尿酸血症更多指南</a></ul>, tagList=[TagDto(tagId=4057, tagName=高尿酸血症)], categoryList=[CategoryDto(categoryId=14, categoryName=肾内科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=7266, appHits=586, showAppHits=23, pcHits=5058, showPcHits=2429, likes=155, shares=22, comments=6, approvalStatus=1, publishedTime=Wed Nov 01 21:17:18 CST 2017, publishedTimeString=2017-10-20, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Wed Nov 01 21:17:18 CST 2017, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 21:22:07 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=中国高尿酸血症与相关疾病诊疗多学科专家共识（英文版）)])
中国高尿酸血症与相关疾病诊疗多学科专家共识（英文版）
下载请点击：
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1010879, encodeId=253f10108e9fd, content=希望能下载到中文版的，更有利于学习！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7fe5582820, createdName=ms4000002107220844, createdTime=Tue Aug 24 09:14:14 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010875, encodeId=7ca310108e5f7, content=开卷有益！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7fe5582820, createdName=ms4000002107220844, createdTime=Tue Aug 24 09:09:30 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=340544, encodeId=77c534054484, content=学习中, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f1ba2215278, createdName=鹏远, createdTime=Fri Aug 24 11:34:19 CST 2018, time=2018-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=266735, encodeId=391e266e355a, content=学习.了解.了解., beContent=null, objectType=guider, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/07/d51783575d8d90eaa8b668d568aa6e50.jpg, createdBy=909f109204, createdName=liuweigang, createdTime=Mon Dec 04 12:59:29 CST 2017, time=2017-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=263911, encodeId=b36c26391103, content=学习了.不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/07/d51783575d8d90eaa8b668d568aa6e50.jpg, createdBy=909f109204, createdName=liuweigang, createdTime=Fri Nov 24 09:52:08 CST 2017, time=2017-11-24, status=1, ipAttribution=)]
    2021-08-24 ms4000002107220844

    希望能下载到中文版的，更有利于学习！

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1010879, encodeId=253f10108e9fd, content=希望能下载到中文版的，更有利于学习！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7fe5582820, createdName=ms4000002107220844, createdTime=Tue Aug 24 09:14:14 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010875, encodeId=7ca310108e5f7, content=开卷有益！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7fe5582820, createdName=ms4000002107220844, createdTime=Tue Aug 24 09:09:30 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=340544, encodeId=77c534054484, content=学习中, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f1ba2215278, createdName=鹏远, createdTime=Fri Aug 24 11:34:19 CST 2018, time=2018-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=266735, encodeId=391e266e355a, content=学习.了解.了解., beContent=null, objectType=guider, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/07/d51783575d8d90eaa8b668d568aa6e50.jpg, createdBy=909f109204, createdName=liuweigang, createdTime=Mon Dec 04 12:59:29 CST 2017, time=2017-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=263911, encodeId=b36c26391103, content=学习了.不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/07/d51783575d8d90eaa8b668d568aa6e50.jpg, createdBy=909f109204, createdName=liuweigang, createdTime=Fri Nov 24 09:52:08 CST 2017, time=2017-11-24, status=1, ipAttribution=)]
    2021-08-24 ms4000002107220844

    开卷有益！

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1010879, encodeId=253f10108e9fd, content=希望能下载到中文版的，更有利于学习！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7fe5582820, createdName=ms4000002107220844, createdTime=Tue Aug 24 09:14:14 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010875, encodeId=7ca310108e5f7, content=开卷有益！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7fe5582820, createdName=ms4000002107220844, createdTime=Tue Aug 24 09:09:30 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=340544, encodeId=77c534054484, content=学习中, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f1ba2215278, createdName=鹏远, createdTime=Fri Aug 24 11:34:19 CST 2018, time=2018-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=266735, encodeId=391e266e355a, content=学习.了解.了解., beContent=null, objectType=guider, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/07/d51783575d8d90eaa8b668d568aa6e50.jpg, createdBy=909f109204, createdName=liuweigang, createdTime=Mon Dec 04 12:59:29 CST 2017, time=2017-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=263911, encodeId=b36c26391103, content=学习了.不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/07/d51783575d8d90eaa8b668d568aa6e50.jpg, createdBy=909f109204, createdName=liuweigang, createdTime=Fri Nov 24 09:52:08 CST 2017, time=2017-11-24, status=1, ipAttribution=)]
    2018-08-24 鹏远

    学习中

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1010879, encodeId=253f10108e9fd, content=希望能下载到中文版的，更有利于学习！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7fe5582820, createdName=ms4000002107220844, createdTime=Tue Aug 24 09:14:14 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010875, encodeId=7ca310108e5f7, content=开卷有益！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7fe5582820, createdName=ms4000002107220844, createdTime=Tue Aug 24 09:09:30 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=340544, encodeId=77c534054484, content=学习中, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f1ba2215278, createdName=鹏远, createdTime=Fri Aug 24 11:34:19 CST 2018, time=2018-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=266735, encodeId=391e266e355a, content=学习.了解.了解., beContent=null, objectType=guider, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/07/d51783575d8d90eaa8b668d568aa6e50.jpg, createdBy=909f109204, createdName=liuweigang, createdTime=Mon Dec 04 12:59:29 CST 2017, time=2017-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=263911, encodeId=b36c26391103, content=学习了.不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/07/d51783575d8d90eaa8b668d568aa6e50.jpg, createdBy=909f109204, createdName=liuweigang, createdTime=Fri Nov 24 09:52:08 CST 2017, time=2017-11-24, status=1, ipAttribution=)]
    2017-12-04 liuweigang

    学习.了解.了解.

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1010879, encodeId=253f10108e9fd, content=希望能下载到中文版的，更有利于学习！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7fe5582820, createdName=ms4000002107220844, createdTime=Tue Aug 24 09:14:14 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010875, encodeId=7ca310108e5f7, content=开卷有益！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7fe5582820, createdName=ms4000002107220844, createdTime=Tue Aug 24 09:09:30 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=340544, encodeId=77c534054484, content=学习中, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f1ba2215278, createdName=鹏远, createdTime=Fri Aug 24 11:34:19 CST 2018, time=2018-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=266735, encodeId=391e266e355a, content=学习.了解.了解., beContent=null, objectType=guider, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/07/d51783575d8d90eaa8b668d568aa6e50.jpg, createdBy=909f109204, createdName=liuweigang, createdTime=Mon Dec 04 12:59:29 CST 2017, time=2017-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=263911, encodeId=b36c26391103, content=学习了.不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/07/d51783575d8d90eaa8b668d568aa6e50.jpg, createdBy=909f109204, createdName=liuweigang, createdTime=Fri Nov 24 09:52:08 CST 2017, time=2017-11-24, status=1, ipAttribution=)]
    2017-11-24 liuweigang

    学习了.不错

    0

相关指南

中国慢性肾脏病患者合并高尿酸血症诊治专家共识

中国慢性肾脏病患者合并高尿酸血症诊治共识专家组 · 2017-06-30

中国高尿酸血症相关疾病诊疗多学科专家共识

肾脏病相关专家小组（统称） · 2017-03-30

中国肾脏疾病高尿酸血症诊治的实践指南（2017版）

中国医师协会肾内科医师分会 · 2017-07-04

高尿酸血症和痛风治疗的中国专家共识

中华医学会内分泌学分会(CSE,Chinese Society of Endocrinology) · 2013-11-01